United States · FDA National Drug Code directory
Typhim Vi
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 49281-790_7d707448-cc80-4364-8aa5-d782f375360e
- Product NDC
- 49281-790
- Form
- INJECTION, SOLUTION
- Composition / generic term
- SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN
- Labeler
- Sanofi Vaccines US Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 19941128
- Source listing expiry
- 20271231
Source-listed ingredients
- SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN — 25 ug/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 PACKAGE (49281-790-20) / 10 mL in 1 VIAL, MULTI-DOSE (49281-790-38) · 49281-790-20
- 1 SYRINGE in 1 PACKAGE (49281-790-51) / .5 mL in 1 SYRINGE (49281-790-88) · 49281-790-51
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →